| hnRNP proteins and splicing control R Martinez-Contreras, P Cloutier, L Shkreta, JF Fisette, T Revil, B Chabot Alternative splicing in the postgenomic era, 123-147, 2007 | 481 | 2007 |
| Defective control of pre–messenger RNA splicing in human disease B Chabot, L Shkreta Journal of Cell Biology 212 (1), 13-27, 2016 | 233 | 2016 |
| The RNA splicing response to DNA damage L Shkreta, B Chabot Biomolecules 5 (4), 2935-2977, 2015 | 147 | 2015 |
| Proteins associated with the exon junction complex also control the alternative splicing of apoptotic regulators L Michelle, A Cloutier, J Toutant, L Shkreta, P Thibault, M Durand, ... Molecular and cellular biology 32 (5), 954-967, 2012 | 136 | 2012 |
| TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis JE Deshaies, L Shkreta, AJ Moszczynski, H Sidibé, S Semmler, A Fouillen, ... Brain 141 (5), 1320-1333, 2018 | 132 | 2018 |
| Insulin-like growth factor binding protein-5 (IGFBP-5) potentially regulates programmed cell death and plasminogen activation in the mammary gland E Tonner, G Allan, L Shkreta, J Webster, C Bruce, A Whitelaw, DJ Flint Biology of the Mammary Gland, 45-53, 2002 | 99 | 2002 |
| Antagonistic effects of the SRp30c protein and cryptic 5′ splice sites on the alternative splicing of the apoptotic regulator Bcl-x P Cloutier, J Toutant, L Shkreta, S Goekjian, T Revil, B Chabot Journal of Biological Chemistry 283 (31), 21315-21324, 2008 | 88 | 2008 |
| Protein kinase C-dependent control of Bcl-x alternative splicing T Revil, J Toutant, L Shkreta, D Garneau, P Cloutier, B Chabot Molecular and cellular biology, 2007 | 87 | 2007 |
| Anticancer drugs affect the alternative splicing of Bcl-x and other human apoptotic genes L Shkreta, U Froehlich, ER Paquet, J Toutant, SA Elela, B Chabot Molecular cancer therapeutics 7 (6), 1398-1409, 2008 | 86 | 2008 |
| The effect of plasminogen activator inhibitor type 1 on apoptosis DJ Schneider, Y Chen, BE Sobel Thrombosis and haemostasis 100 (12), 1037-1040, 2008 | 75 | 2008 |
| hnRNP I/PTB can antagonize the splicing repressor activity of SRp30c C Paradis, P Cloutier, L Shkreta, J Toutant, K Klarskov, B Chabot Rna 13 (8), 1287-1300, 2007 | 73 | 2007 |
| SRSF10 connects DNA damage to the alternative splicing of transcripts encoding apoptosis, cell-cycle control, and DNA repair factors L Shkreta, J Toutant, M Durand, JL Manley, B Chabot Cell reports 17 (8), 1990-2003, 2016 | 68 | 2016 |
| The DNA damage response pathway regulates the alternative splicing of the apoptotic mediator Bcl-x L Shkreta, L Michelle, J Toutant, ML Tremblay, B Chabot Journal of biological chemistry 286 (1), 331-340, 2011 | 65 | 2011 |
| Cancer-associated perturbations in alternative pre-messenger RNA splicing L Shkreta, B Bell, T Revil, JP Venables, P Prinos, SA Elela, B Chabot RNA and Cancer, 41-94, 2013 | 63 | 2013 |
| Modulation of the splicing regulatory function of SRSF10 by a novel compound that impairs HIV-1 replication L Shkreta, M Blanchette, J Toutant, E Wilhelm, B Bell, BA Story, ... Nucleic acids research 45 (7), 4051-4067, 2017 | 43 | 2017 |
| Redirecting splicing with bifunctional oligonucleotides JP Brosseau, JF Lucier, AA Lamarche, L Shkreta, D Gendron, E Lapointe, ... Nucleic acids research 42 (6), e40-e40, 2014 | 41 | 2014 |
| hnRNP A1/A2 and Sam68 collaborate with SRSF10 to control the alternative splicing response to oxaliplatin-mediated DNA damage A Cloutier, L Shkreta, J Toutant, M Durand, P Thibault, B Chabot Scientific reports 8 (1), 2206, 2018 | 36 | 2018 |
| A novel class of inhibitors that target SRSF10 and promote p53-mediated cytotoxicity on human colorectal cancer cells M Sohail, L Shkreta, J Toutant, S Rabea, JP Babeu, C Huard, ... NAR cancer 3 (2), zcab019, 2021 | 15 | 2021 |
| Interplay between CMGC kinases targeting SR proteins and viral replication: splicing and beyond F Pastor, L Shkreta, B Chabot, D Durantel, A Salvetti Frontiers in Microbiology 12, 658721, 2021 | 13 | 2021 |
| Pre-mRNA alternative splicing in cancer: functional impact, molecular mechanisms and therapeutic perspectives T Revil, L Shkreta, B Chabot Bulletin du Cancer 93 (9), 909-919, 2006 | 13 | 2006 |
